Trends in prostate cancer mortality among black men and white men in the United States (Q73102834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Trends in prostate cancer mortality among black men and white men in the United States (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

United States of America

1 reference

Kenneth C Chu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Robert E Tarone

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Harold P Freeman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1507-1516

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

Rise in prostatic cancer incidence associated with increased use of transurethral resection

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

The role of increasing detection in the rising incidence of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Prostate cancer incidence and mortality rates among white and black men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Why is the prostate cancer death rate declining in the United States?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Mortality rates by stage-at-diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Evaluation of birth cohort patterns in population disease rates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Generalized Linear Models

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Re: "Temporal trends in diabetes mortality among American Indians and Hispanics in New Mexico: birth cohort and period effects"

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

International trends and patterns of prostate cancer incidence and mortality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

International trends in prostate-cancer mortality in the "PSA ERA".

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Birth cohort and calendar period trends in breast cancer mortality in the United States and Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Comparison of trends in prostate-cancer mortality in England and Wales and the USA.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Eradication of a disease: how we cured symptomless prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

American Cancer Society guidelines for the early detection of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11212

7 January 2021

Identifiers

DOI

10.1002/CNCR.11212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627516%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference